Uncategorized - December 23, 2014
Researchers Study Link Between Pandemrix, Narcolepsy
A research team from Finland thinks it knows why about 800 people out of the more than 30 million who received GlaxoSmithKline’s Pandemrix developed narcolepsy. Comparing Pandemrix with Arepanrix, a vaccine used in Canada with the same adjuvant, the researchers found that Pandemrix had more of one structurally altered viral nucleoprotein–a disparity lead researcher Outi […]